Innovation1 Biotech Inc. Quarterly Accrued Liabilities, Current in USD from Q3 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Innovation1 Biotech Inc. quarterly Accrued Liabilities, Current history and growth rate from Q3 2018 to Q3 2023.
  • Innovation1 Biotech Inc. Accrued Liabilities, Current for the quarter ending August 31, 2023 was $1.07M, a 2610% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.07M +$1.03M +2610% Aug 31, 2023 10-K 2024-01-17
Q2 2023 $540K +$504K +1418% May 31, 2023 10-Q 2023-09-13
Q1 2023 $558K +$546K +4361% Feb 28, 2023 10-Q 2023-05-30
Q4 2022 $98.9K -$4.43K -4.29% Nov 30, 2022 10-Q 2023-01-17
Q3 2022 $39.6K +$37.5K +1824% Aug 31, 2022 10-K 2024-01-17
Q2 2022 $35.6K May 31, 2022 10-Q 2022-07-14
Q1 2022 $12.5K Feb 28, 2022 10-Q 2022-04-15
Q4 2021 $103K Nov 30, 2021 10-Q/A 2022-02-01
Q3 2021 $2.06K Aug 31, 2021 10-K 2022-12-15
Q4 2019 $2.08K +$1.48K +247% Nov 30, 2019 10-Q 2020-01-21
Q3 2019 $1.01K +$539 +113% Aug 31, 2019 10-Q 2020-01-21
Q2 2019 $845 May 31, 2019 10-Q 2019-07-18
Q1 2019 $599 Feb 28, 2019 10-Q 2019-04-15
Q4 2018 $599 Nov 30, 2018 10-Q 2019-01-18
Q3 2018 $475 Aug 31, 2018 10-K 2019-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.